The primary barrier to a cure is the , which evades both the immune system and ART. If CD32 can reliably identify these cells, it could enable targeted "kill" strategies:
Further research is needed to fully understand the role of CD32 in HIV pathogenesis and latency. Some areas of investigation include: cd32 hiv
|
Ends July 14
The primary barrier to a cure is the , which evades both the immune system and ART. If CD32 can reliably identify these cells, it could enable targeted "kill" strategies:
Further research is needed to fully understand the role of CD32 in HIV pathogenesis and latency. Some areas of investigation include: